Dividends Calendar Earnings Calendar
TLRY

TLRY | Tilray, Inc.

Tilray, Inc.
Category: Pharmaceutical company
  • Industry: Drug Manufacturers - Specialty & Generic

Quick infos

  • Headquarters:   Nanaimo, Canada

Trade prices

  • Volume: 80.2M
  • Market Cap: 1.41B
  • Prev closed:
  • Open: 5.82
  • High: 7.07
  • Low: 5.68
  • 52 week low: 4.78
  • 52 week high: 24.68
  • Dividends:No Dividends

Next ER: January 9, 2023  Before Market Opens



Top Stories (TLRY)



    About the Company

    Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Nanaimo, British Columbia. Tilray also has operations in Australia & New Zealand, Germany, Portugal, and Latin America.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    July 6, 2023
    April 6, 2023
    April 5, 2023
    January 9, 2023-0.06 / -0.06144.1M / 156.85M
    October 7, 2022-0.13 / -0.0675153.21M / 155.87M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 16, 2022 4.20 4.33
    4.48
    4.12
    43.35M -2.1%
    Aug 15, 2022 4.29 4.00
    4.38
    3.99
    41.28M 6.45%
    Aug 12, 2022 4.03 3.96
    4.06
    3.83
    23.53M 4.68%
    Aug 11, 2022 3.85 4.18
    4.27
    3.85
    28.58M -5.17%
    Aug 10, 2022 4.06 4.00
    4.13
    3.84
    29.98M 5.73%
    Aug 9, 2022 3.84 4.17
    4.22
    3.82
    32.01M -10.7%
    Aug 8, 2022 4.30 3.93
    4.43
    3.90
    47.66M 10.26%
    Aug 5, 2022 3.90 3.88
    4.02
    3.80
    24.71M -3.23%
    Aug 4, 2022 4.03 3.83
    4.14
    3.79
    28.59M 3.87%
    Aug 3, 2022 3.88 3.97
    4.05
    3.80
    25.69M -0.51%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:750

    News

    News for (TLRY)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Brendan Kennedy
    • CFO :  Mark Castaneda
    • General Counsel :  Dara Redler

    Talk about Tilray, Inc. below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Jan 9, 2023 (Same day)

    jef tlry ayi ibio evfm wdfc etwo 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 27
    HOLD 64
    SELL 9

    Their Official Profiles 

    WikipediaTwitter

    Peers / Similar stocks 

    xlv 

    Other stocks 

    csco baba asna jpm sig cmc mtb chl etr afsi dxc docu 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.